Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2026 16:01 ET | Source: Traws Pharma, Inc.

Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights

Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical antiviral activity, Ratutrelvir topline Phase 2a data show...
April 15, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Collation Shrink Films Market Size/Share Worth USD 9 Billion by 2035 at a 7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, April 15, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Collation Shrink Films Market Size, Trends and Insights By Product Type...
April 15, 2026 10:44 ET | Source: Research and Markets

Tomato Processing Market Report 2026: Insights and Growth Outlook by Product Type, Distribution Channel, and Region with Profiles of Key Competitors

Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Tomato Processing Market Report by Product Type, Distribution Channel, and Region 2026-2034" has been added to ResearchAndMarkets.com's offering. ...
April 15, 2026 10:29 ET | Source: Research and Markets

GMP Principles in Vaccine Manufacturing Course: Platforms, Raw Material, Production, Quality Control, Quality Assurance, Storage, and Distribution Processes (ONLINE: June 16th-17th, 2026)

Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "GMP Principles in Vaccine Manufacturing (June 16th - June 17th, 2026)" training has been added to ResearchAndMarkets.com's offering.In this two-day...
April 15, 2026 08:15 ET | Source: Traws Pharma, Inc.

Traws Pharma Announces Up to $60 Million Private Placement Financing

Financing led by Sirenia Capital Management LP advances Traws Pharma's influenza program through a human challenge trial for tivoxavir marboxil in the United Kingdom NEWTOWN, Pa., April 15, 2026 ...
April 15, 2026 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:...
April 15, 2026 06:15 ET | Source: Comstock Inc.

Comstock Releases Shareholder Letter and Reminder of AGM Registration

VIRGINIA CITY, Nev., April 15, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE American: LODE) (“Comstock” and the “Company”) today announced that its chief executive officer issued the following...
April 15, 2026 05:30 ET | Source: SNS Insider pvt ltd

Rapid Diagnostic Tests Market Size is Expected to reach USD 67.83 Billion by 2035 Owing to the Increasing Number of Infections Globally | SNS Insider

Rapid diagnostic tests market grows with rising infections, home testing adoption, driven by tech advances, fast results, and expanding healthcare access.
April 15, 2026 02:18 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (AAD) Annual...
April 15, 2026 01:00 ET | Source: BioVersys

BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026

BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex...